CCR5-ligand decorated rilpivirine lipid-based nanoparticles for sustained antiretroviral responses.

Nat Commun · 2025 · PMC11711180 · PMID 39779664

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

We observed a decreasing trend in HIV-1 positive cells from the LBNP-RPV group to the LBNP-RPV-CCR5 group, indicating that the LBNP-RPV-CCR5 treatment provided improved viral suppression.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.